HCV Quasispecies Dynamics in HIV/HCV Coinfected Patients
Author Information
Author(s): Bernini Flavia, Ebranati Erika, De Maddalena Chiara, Shkjezi Renata, Milazzo Laura, Lo Presti Alessandra, Ciccozzi Massimo, Galli Massimo, Zehender Gianguglielmo
Primary Institution: Department of Clinical Sciences “L. Sacco”, University of Milan, Milan, Italy
Hypothesis
The study investigates the role of the immune system in driving the evolution of the HCV quasispecies in HIV/HCV coinfected individuals under HAART.
Conclusion
The study found that HCV quasispecies undergo rapid evolution in HAART-treated patients, particularly in immunological responders, due to increased viral replication activity.
Supporting Evidence
- The intra-host evolutionary rates of HCV quasispecies were 10 times higher in subjects treated with HAART than in controls.
- Significant positive selection pressure was detected in half of the patients under HAART.
- An exponential growth of the quasispecies populations was observed in immunological responders.
Takeaway
This study shows that when people with HIV and hepatitis C get treatment, the virus can change and grow quickly, especially if their immune system gets stronger.
Methodology
The study involved clonal sequence analysis of HCV samples from patients before and after HAART, using Bayesian methods to estimate evolutionary rates and population dynamics.
Limitations
The study had a small sample size and a relatively low number of clones analyzed per sample.
Participant Demographics
The study included 8 HIV/HCV coinfected patients, with 5 immunological responders and 3 non-responders, and 2 HIV-negative controls.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website